Search results for "CARDIOVASCULAR DISEASE."

showing 10 items of 2331 documents

Mitral and aortic regurgitation in 84 patients with mucopolysaccharidoses

1995

In echocardiographic and necropsy studies nodular thickening of the mitral valve and, less frequently, of the aortic valve has been found in 60%-90% of patients with mucopolysaccharidoses (MPS). Little is known about the haemodynamic consequences of these morphological changes. In this study 84 unselected patients with different enzymatically proven MPS and 84 age and sex matched, healthy persons were studied prospectively by colour Doppler flow mapping. The patients' age ranged from 1 to 47 years (median 8.1 years). Mitral and aortic regurgitation were defined as a holosystolic or holodiastolic jet originating from the valve into the left atrium or the left ventricular outflow tract, respe…

AdultMaleAortic valvemedicine.medical_specialtyAdolescentAortic Valve InsufficiencyHemodynamicsRegurgitation (circulation)Doppler echocardiographyMitral valveInternal medicinemedicineHumansVentricular outflow tractProspective Studiescardiovascular diseasesChildskin and connective tissue diseasesMitral regurgitationmedicine.diagnostic_testbusiness.industryInfantMitral Valve InsufficiencyMiddle AgedMucopolysaccharidosesEchocardiography Doppler ColorSurgerymedicine.anatomical_structureChild PreschoolPediatrics Perinatology and Child Healthcardiovascular systemCardiologyFemaleComplicationbusinessEuropean Journal of Pediatrics
researchProduct

RUPTURE OF A LEFT SINUS OF VALSALVA ANEURYSM INTO THE PULMONARY ARTERY.

2006

Sinus of Valsalva aneurysm is a rare congenital defect and the diagnosis is usually made after it ruptures. Very few cases of non-complicated sinus of Valsalva aneurysm have been published. The anomaly most often involves the right coronary sinus and less frequently the non-coronary sinus. A case with left sinus of Valsalva has not been reported. Since the aortic valve occupies a central position in the base of the heart, rupture of a sinus of Valsalva aneurysm can occur in any of the four heart chambers. Rupture into the pulmonary artery is very rare and is mostly associated with other congenital cardiopathies. ª 2005 The European Society of Cardiology. Published by Elsevier Ltd. All right…

AdultMaleAortic valvemedicine.medical_specialtyHeart.chambersAneurysm RupturedPulmonary ArteryMyocardial ruptureDiagnosis DifferentialAneurysmInternal medicinemedicine.arteryHIV Seropositivityotorhinolaryngologic diseasesHumansMedicineRadiology Nuclear Medicine and imagingcardiovascular diseasesHeart AneurysmSinus (anatomy)Coronary sinusbusiness.industryGeneral MedicineSinus of Valsalvamedicine.diseaseAneurysmEchocardiography Doppler Colorbody regionsmedicine.anatomical_structurePulmonary arterycardiovascular systemCardiologyCardiology and Cardiovascular Medicinebusinesscirculatory and respiratory physiologyRupture into the pulmonary artery
researchProduct

Physician attitudes to blood pressure control

2011

OBJECTIVES: The Supporting Hypertension Awareness and Research Europe-wide (SHARE) physician survey aimed to qualify the key challenges that physicians face when trying to get patients to blood pressure (BP) goal. METHODS: The SHARE survey was open to physicians involved in the treatment of patients with hypertension, was anonymous, and was designed to take 15 min to complete. The survey included 45 questions covering physicians' demographic information, views on the BP targets recommended by the European Society of Hypertension-European Society of Cardiology guidelines, opinions on acceptable levels of BP control, and perceptions about the challenges associated with getting patients to BP …

AdultMaleBlood pressure controlHealth Knowledge Attitudes Practicemedicine.medical_specialtyBiomedical ResearchAttitude of Health PersonnelPhysiologyElevated bpMEDLINEBlood PressureRisk AssessmentPhysiciansSurveys and QuestionnairesInternal MedicineHumansMedicinePractice Patterns Physicians'Antihypertensive Agentsbusiness.industryGuideline adherenceGuidelineAwarenessMiddle AgedHealth SurveysEuropeBlood pressureCardiovascular DiseasesPhysician surveyFamily medicineHypertensionFemaleGuideline AdherenceCardiology and Cardiovascular MedicinebusinessRisk assessmentJournal of Hypertension
researchProduct

Actin is a target antigen of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune hepatitis type-1.

1997

Abstract Background/Aim: Anti-neutrophil cytoplasmic antibodies (ANCA) are a group of autoantibodies first associated with Wegener's granulomatosis and microscopic polyangiitis. The signifiance of ANCA in autoimmune hepatitis remains uncertain; the nature of the antigen or antigens has not been defined yet. The purpose of this study was to identify the target antigen of ANCA in patients with autoimmune hepatitis. Method/Results: Sera from 32 type-1 autoimmune hepatitis patients were used in the present study. ANCA were detected in 24 of 32 sera (75%). A diffuse cytoplasmic staining pattern (C-ANCA) was detected in 14 patients; the P-ANCA pattern was observed in 10 patients. An extract of hu…

AdultMaleBlotting WesternEnzyme-Linked Immunosorbent AssayAutoimmune hepatitisTropomyosinMyosinsAntibodies Antineutrophil CytoplasmicAutoimmune DiseasesHepatitisAntigenmedicineHumanscardiovascular diseasesAntigensFluorescent Antibody Technique IndirectAnti-neutrophil cytoplasmic antibodyAgedAutoimmune diseaseHepatitisAged 80 and overHepatologybiologyAutoantibodyActomyosinBlood ProteinsMiddle Agedmedicine.diseaseActinsMolecular WeightImmunologybiology.proteinFemaleAntibodyMicroscopic polyangiitisJournal of hepatology
researchProduct

Non invasive evaluation of endothelial function in patients with Anderson-Fabry disease.

2005

AIM: Fabry's disease is an X-linked recessive abnormality of glycosphingolipid metabolism. Increased levels of endothelial prothrombotic factors have recently been demonstrated in Fabry's disease, whereas endothelial function has not been studied using high resolution ultrasound. METHODS: We enrolled 6 patients (4 male, 2 female; mean age, 37 years) and 12 sex matched control subjects (mean age, 37 years). Patients' exclusion criteria included a prior history of cardiac disease, diabetes and treated or untreated hypertension. Patients underwent: anamnesis, physical examination, EKG, 2-dimensional echocardiography with tissue Doppler, measurement of body weight and height, blood pressure. Bi…

AdultMaleBrachial ArteryFabry's diseaseHyperemiaMiddle Agedendothelial dysfunctionVasodilationElectrocardiographyC-Reactive Proteincardiovascular diseaseRegional Blood Flowrisk factorsFabry DiseaseHumansFemaleEndothelium VascularUltrasonographyInternational angiology : a journal of the International Union of Angiology
researchProduct

Mortality risk among 5‐year survivors of childhood cancer in Germany—Results from the CVSS study (Cardiac and Vascular late Sequelae in long‐term Sur…

2021

The growing population of long-term childhood cancer survivors is at increased risk for severe, therapy-related late effects and premature mortality. The cardiac and vascular late sequelae in long-term survivors of childhood cancer (CVSS) study is a cohort of patients from Germany diagnosed with a neoplasia prior to 15 years of age in the time period 1980 to 1990. Late mortality was evaluated in a total of 4505 individuals who survived 5 years or more after the initial diagnosis (5-year survivors). Survivors with a second primary tumor were excluded. Standardized mortality ratios (SMRs) were calculated. By December 2014, 400 patients had died. Available cause of death information from 188 i…

AdultMaleCancer ResearchPediatricsmedicine.medical_specialtyTime FactorsAdolescentPopulationChildhood cancerYoung AdultCancer SurvivorsCause of DeathGermanyNeoplasmsmedicineHumansMortalityChildeducationRetrospective StudiesCause of deatheducation.field_of_studybusiness.industryInfant NewbornInfantCancerPrognosismedicine.diseaseConfidence intervalSurvival RateOncologyCardiovascular DiseasesChild PreschoolCVSSCohortDisease ProgressionFemalebusinessFollow-Up StudiesCohort studyInternational Journal of Cancer
researchProduct

Cardiovascular Risk in Polycythemia Vera: Thrombotic Risk and Survival: Can Cytoreductive Therapy Be Useful in Patients with Low-Risk Polycythemia Ve…

2019

<b><i>Background/Aims:</i></b> Cardiovascular risk factors are not considered in the current scores for evaluation of the thrombotic risk in myeloproliferative neoplasms, and in polycythemia vera (PV) in particular. Cytoreduction is currently not indicated in low-risk patients with PV, despite the absence or presence of cardiovascular risk factors. Our purpose is to highlight how cardiovascular risk factors in patients with PV increase the thrombotic risk both in low- and high-risk patients. <b><i>Methods:</i></b> We collected and analyzed data from 165 consecutive patients with a diagnosis of PV followed at our institution and compared the fr…

AdultMaleCancer Researchmedicine.medical_specialtyAdolescentPopulationCardiovascular risk factorsKaplan-Meier EstimateSettore MED/15 - Malattie Del SangueCytoreductionYoung AdultPolycythemia veraSurvival dataInternal medicinemedicineHumansIn patienteducationAgedRetrospective StudiesAged 80 and overThrombotic riskeducation.field_of_studybusiness.industryThrombosisCytoreduction Surgical ProceduresHematologyMiddle AgedCardiovascular riskmedicine.diseaseThrombosisPolycythemia veraOncologyCardiovascular DiseasesHeart Disease Risk FactorsRisk stratificationFemalebusinessOncology Research and Treatment
researchProduct

Time-to-cure and cure proportion in solid cancers in France. A population based study.

2019

In cancer care, the cure proportion (P) and time-to-cure (TTC) are important indicators for practitioners, patients, and healthcare policy makers. The recent definition of TTC as the time at which the probability of belonging to the cured group reaches 95% was used for the first time.The data stem from the common database of French cancer registries including 335,358 solid tumours diagnosed between 1995 and 2009 at 27 sites. P and TTC were estimated through a flexible parametric net survival cure model for each cancer site, sex, and age at diagnosis with acceptable assumption of cure (excess mortality rate ≤0.05).TTC was ≤5 years and P was80% for skin melanoma and thyroid and testis cancers…

AdultMaleCancer Researchmedicine.medical_specialtyDatabases FactualEpidemiology[SDV]Life Sciences [q-bio]03 medical and health sciences0302 clinical medicineInternal medicineNeoplasmsEpidemiologymedicineHumanscardiovascular diseases030212 general & internal medicineRegistriesNet SurvivalThyroid cancerAgedbusiness.industryThyroidCancerMiddle Agedmedicine.disease3. Good healthPopulation based studySurvival Ratemedicine.anatomical_structureOncology030220 oncology & carcinogenesisNational databaseFemaleFranceSkin melanomabusinessCancer epidemiology
researchProduct

Integrated Small Dense Low-density Lipoprotein Profile in Cardiovascular Disease and Cancer: A longitudinal study

2019

Background/Aim: Low-density lipoproteins (LDL) are a heterogeneous class of particles that differ in size and density from each other. Small dense LDL (sdLDL) particles are considered more atherogenic than larger particles. The aim of the study was to evaluate serum levels of sdLDL in patients who died from cardiovascular diseases (CVD) or cancer in a cohort of patients followed up in the De Bellis Research Hospital for 20 years. Patients and Methods: A total of 75 participants who died of cancer and 87 who died of CVD were enrolled and they were matched for age and sex with 135 healthy controls, i.e. without CVD or cancer and are still alive. Results: Patients who died from cancer had the …

AdultMaleCancer Researchmedicine.medical_specialtyLongitudinal studySmall dense ldlDiseaseAge and sexGastroenterologychemistry.chemical_compoundRisk FactorsInternal medicineNeoplasmsMedicineHumansIn patientLongitudinal StudiesAgedbusiness.industryCancersdLDL cardiovascular disease cancerGeneral MedicineMiddle Agedmedicine.diseasePrognosisLipoproteins LDLOncologychemistryCardiovascular DiseasesLow-density lipoproteinCase-Control StudiesCohortFemalebusinessBiomarkersFollow-Up Studies
researchProduct

Management of venous thromboembolism in patients with acute leukemia at high bleeding risk: a multi-center study

2016

In the last decades, evaluation of clinically relevant thrombotic complications in patients with acute leukemia (AL) has been poorly investigated. The authors performed a multi-center study to evaluate the management of symptomatic venous thromboembolism (VTE) in adult patients with AL. The intention was to find as clinically relevant the following: symptomatic Venous Thrombosis (VT) occurred in typical (lower limbs) and atypical (cerebral, upper limbs, abdominal, etc) sites with or without pulmonary embolism (PE). Over a population of 1461 patients with AL, 22 cases of symptomatic VTE were recorded in hospitalized patients with a mean age of 54.6 years. The absolute incidence of VTE was 1.…

AdultMaleCancer Researchmedicine.medical_specialtymedicine.drug_classmedicine.medical_treatmentPopulationLow molecular weight heparinHemorrhage030204 cardiovascular system & hematologyYoung Adult03 medical and health sciences0302 clinical medicineVenous thrombosisLow Molecular Weight HeparinHumansMedicineacute leukemiacardiovascular diseaseseducationAgedAged 80 and overVenous ThrombosisAcute leukemiaeducation.field_of_studyAcute leukemiaChemotherapyLeukemiabusiness.industrylow molecular weight heparinIncidenceIncidence (epidemiology)Disease ManagementVenous ThromboembolismHematologyMiddle Agedmedicine.diseasePulmonary embolismSurgeryVenous thrombosisOncology030220 oncology & carcinogenesisAcute DiseaseFemaleacute leukemia; low molecular weight heparin; Venous thrombosisbusinessSettore MED/15 - Malattie del SangueVenous thromboembolismLeukemia & Lymphoma
researchProduct